GitLab soars on plan for new AI-powered product

By Chibuike Oguh NEW YORK (Reuters) – Shares of GitLab Inc jumped more than 35% on Tuesday after the software development platform announced plans to launch a revenue-boosting artificial intelligence (AI)-powered product. GitLab, widely used by software developers for coding work, will add a “ModelOps” feature to its main “DevSecOps” platform with new capabilities including…

Read More

OpenAI CEO has no IPO plan due to ‘strange’ company structure

By Supantha Mukherjee STOCKHOLM (Reuters) – Microsoft-backed OpenAI, the company behind ChatGPT, has no plans to go public any time soon, Chief Executive Sam Altman said at a conference in Abu Dhabi. “When we develop super intelligence, we are likely to make some decisions that most investors would look at very strangely,” Altman said. “I…

Read More

Hollywood actors authorize strike as writers still out

By Lisa Richwine LOS ANGELES (Reuters) -Hollywood’s actors union voted to authorize a strike if contract talks break down, turning up the heat on major film and television studios already grappling with a monthlong work stoppage by writers. After voting closed on Monday, SAG-AFTRA said 97.91% of ballots cast supported a strike authorization. Nearly 65,000…

Read More

U.S. Senate leader schedules classified AI briefings

WASHINGTON (Reuters) – Senate Majority Leader Chuck Schumer said on Tuesday he has scheduled three briefings for senators on artificial intelligence, including the first classified briefing on the topic. In a letter to colleagues on Tuesday, the Democratic leader said senators need to deepen their understanding of artificial intelligence. “AI is already changing our world,…

Read More

CEO of Germany’s Merck: decoupling from China would be at huge economic cost

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) -The CEO of German technology group Merck KGaA said that unravelling trade ties with China would come at great economic cost and she was banking on dialogue to ease tensions between Beijing and Western powers. Belen Garijo, the Spanish CEO of the German drugmaker and manufacturer of…

Read More